MRK Merck & Company, Inc. | US58933Y1055
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 70.115.955.810 | 66.879.928.889 | 4.84% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 9,66 | 2,74 | 251.83% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 18 | 18 | 0.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |